{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T00:26:39Z","timestamp":1716942399776},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,27]]},"DOI":"10.7759\/cureus.61196","type":"journal-article","created":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T03:15:22Z","timestamp":1716866122000},"source":"Crossref","is-referenced-by-count":0,"title":["CT-Based Hounsfield Units for Pre-donation Liver Steatosis Assessment: Enhancing Transplant Outcomes and Efficiency"],"prefix":"10.7759","author":[{"given":"Jeffrey","family":"Campsen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carrie","family":"Poole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/lt.25408","article-title":"The \"skinny\" on assessment and utilization of steatotic liver grafts: a systematic review","volume":"25","author":"Croome KP","year":"2019","unstructured":"Croome KP, Lee DD, Taner CB. The \"skinny\" on assessment and utilization of steatotic liver grafts: a systematic review. Liver Transpl. 2019, 25:488-99. 10.1002\/lt.25408","journal-title":"Liver Transpl"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2006.01242.x","article-title":"Characteristics associated with liver graft failure: the concept of a donor risk index","volume":"6","author":"Feng S","year":"2006","unstructured":"Feng S, Goodrich NP, Bragg-Gresham JL, et al.. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant. 2006, 6:783-90. 10.1111\/j.1600-6143.2006.01242.x","journal-title":"Am J Transplant"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1053\/jlts.2002.31747","article-title":"Current practice regarding the use of fatty livers: a trans-Atlantic survey","volume":"8","author":"Imber CJ","year":"2002","unstructured":"Imber CJ, St Peter SD, Lopez I, Guiver L, Friend PJ. Current practice regarding the use of fatty livers: a trans-Atlantic survey. Liver Transpl. 2002, 8:545-9. 10.1053\/jlts.2002.31747","journal-title":"Liver Transpl"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani N","year":"2018","unstructured":"Chalasani N, Younossi Z, Lavine JE, et al.. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2018, 67:328-57. 10.1002\/hep.29367","journal-title":"Hepatology"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2010.11.004","article-title":"Liver transplantation using fatty livers: always feasible?","volume":"54","author":"McCormack L","year":"2011","unstructured":"McCormack L, Dutkowski P, El-Badry AM, Clavien PA. Liver transplantation using fatty livers: always feasible?. J Hepatol. 2011, 54:1055-62. 10.1016\/j.jhep.2010.11.004","journal-title":"J Hepatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/cld.716","article-title":"Diagnostic challenges of nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis","volume":"11","author":"Cleveland E","year":"2018","unstructured":"Cleveland E, Bandy A, VanWagner LB. Diagnostic challenges of nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis. Clin Liver Dis (Hoboken). 2018, 11:98-104. 10.1002\/cld.716","journal-title":"Clin Liver Dis (Hoboken)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/oby.20624","article-title":"Epicardial fat thickness and nonalcoholic fatty liver disease in obese subjects","volume":"22","author":"Iacobellis G","year":"2014","unstructured":"Iacobellis G, Barbarini G, Letizia C, Barbaro G. Epicardial fat thickness and nonalcoholic fatty liver disease in obese subjects. Obesity (Silver Spring). 2014, 22:332-6. 10.1002\/oby.20624","journal-title":"Obesity (Silver Spring)"},{"key":"ref8","doi-asserted-by":"crossref","DOI":"10.1007\/s11547-020-01321-9","article-title":"Association of hepatic steatosis with epicardial fat volume and coronary artery disease in symptomatic patients","volume":"126","author":"Ledda RE","year":"2021","unstructured":"Ledda RE, Milanese G, Cademartiri F, et al.. Association of hepatic steatosis with epicardial fat volume and coronary artery disease in symptomatic patients. Radiol Med. 2021, 126:652-60.","journal-title":"Radiol Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2002.35354","article-title":"The utility of radiological imaging in nonalcoholic fatty liver disease","volume":"123","author":"Saadeh S","year":"2002","unstructured":"Saadeh S, Younossi ZM, Remer EM, et al.. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology. 2002, 123:745-50. 10.1053\/gast.2002.35354","journal-title":"Gastroenterology"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3978\/j.issn.2223-3652.2012.04.03","article-title":"Epicardial and thoracic fat - noninvasive measurement and clinical implications","volume":"2","author":"Dey D","year":"2012","unstructured":"Dey D, Nakazato R, Li D, Berman DS. Epicardial and thoracic fat - noninvasive measurement and clinical implications. Cardiovasc Diagn Ther. 2012, 2:85-93. 10.3978\/j.issn.2223-3652.2012.04.03","journal-title":"Cardiovasc Diagn Ther"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehr453","article-title":"Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor?","volume":"33","author":"Bhatia LS","year":"2012","unstructured":"Bhatia LS, Curzen NP, Calder PC, Byrne CD. Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor?. Eur Heart J. 2012, 33:1190-200. 10.1093\/eurheartj\/ehr453","journal-title":"Eur Heart J"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph16173104","article-title":"Cardiovascular risk in non-alcoholic fatty liver disease: mechanisms and therapeutic implications","volume":"16","author":"Tana C","year":"2019","unstructured":"Tana C, Ballestri S, Ricci F, et al.. Cardiovascular risk in non-alcoholic fatty liver disease: mechanisms and therapeutic implications. Int J Environ Res Public Health. 2019, 16:10.3390\/ijerph16173104","journal-title":"Int J Environ Res Public Health"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2017-313884","article-title":"Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases","volume":"66","author":"Adams LA","year":"2017","unstructured":"Adams LA, Anstee QM, Tilg H, Targher G. Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases. Gut. 2017, 66:1138-53. 10.1136\/gutjnl-2017-313884","journal-title":"Gut"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10092204","article-title":"Systematic review and meta-analysis of the usefulness of epicardial fat thickness as a non-invasive marker of the presence and severity of nonalcoholic fatty liver disease","volume":"10","author":"Orci LA","year":"2022","unstructured":"Orci LA, Jornayvaz FR, Toso C, Gariani K. Systematic review and meta-analysis of the usefulness of epicardial fat thickness as a non-invasive marker of the presence and severity of nonalcoholic fatty liver disease. Biomedicines. 2022, 10:10.3390\/biomedicines10092204","journal-title":"Biomedicines"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.17179\/excli2021-3815","article-title":"The association between epicardial adipose tissue and non-alcoholic fatty liver disease: a systematic review of existing human studies","volume":"20","author":"Emamat H","year":"2021","unstructured":"Emamat H, Tangestani H, Behrad Nasab M, Ghalandari H, Hekmatdoost A. The association between epicardial adipose tissue and non-alcoholic fatty liver disease: a systematic review of existing human studies. EXCLI J. 2021, 20:1096-105. 10.17179\/excli2021-3815","journal-title":"EXCLI J"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0162473","article-title":"Epicardial adipose tissue (EAT) thickness is associated with cardiovascular and liver damage in nonalcoholic fatty liver disease","volume":"11","author":"Fracanzani AL","year":"2016","unstructured":"Fracanzani AL, Pisano G, Consonni D, et al.. Epicardial adipose tissue (EAT) thickness is associated with cardiovascular and liver damage in nonalcoholic fatty liver disease. PLoS One. 2016, 11:e0162473. 10.1371\/journal.pone.0162473","journal-title":"PLoS One"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/3962785","article-title":"The impact of steatosis on the outcome of liver transplantation: a meta-analysis","volume":"2019","author":"Zhang QY","year":"2019","unstructured":"Zhang QY, Zhang QF, Zhang DZ. The impact of steatosis on the outcome of liver transplantation: a meta-analysis. Biomed Res Int. 2019, 2019:3962785. 10.1155\/2019\/3962785","journal-title":"Biomed Res Int"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/liv.14669","article-title":"Prognostic accuracy of FIB-4, NAFLD fibrosis score and APRI for NAFLD-related events: a systematic review","volume":"41","author":"Lee J","year":"2021","unstructured":"Lee J, Vali Y, Boursier J, Spijker R, Anstee QM, Bossuyt PM, Zafarmand MH. Prognostic accuracy of FIB-4, NAFLD fibrosis score and APRI for NAFLD-related events: a systematic review. Liver Int. 2021, 41:261-70. 10.1111\/liv.14669","journal-title":"Liver Int"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/242815-ct-based-hounsfield-units-for-pre-donation-liver-steatosis-assessment-enhancing-transplant-outcomes-and-efficiency","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T03:15:26Z","timestamp":1716866126000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/242815-ct-based-hounsfield-units-for-pre-donation-liver-steatosis-assessment-enhancing-transplant-outcomes-and-efficiency"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,27]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.61196","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5,27]]}}}